SCHEMBL8710180

SCHEMBL8710180

C(=Cc1ccccc1OCc1ccccc1)Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 1/20 0.66
CDK1 P06493 1/20 0.66
CDK4 P11802 1/20 0.66
CCNB1 P14635 1/20 0.66
CCND1 P24385 1/20 0.66
CCNB3 Q8WWL7 1/20 0.66
PTGER4 P35408 4/20 0.59
PTGER2 P43116 4/20 0.59
PTGER1 P34995 3/20 0.59
PTGER3 P43115 3/20 0.59
MAPT P10636 3/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 3/20 0.47
GAA P10253 1/20 0.47
MAOB P27338 1/20 0.47
HTR1A P08908 2/20 0.46
DRD2 P14416 1/20 0.46
POLB P06746 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8710177 1.00 CCNB2 (0.66) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL8522682 0.87 PTGER4 (0.58) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL8522681 0.87 PTGER4 (0.58) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL6183746 0.87 CCNB2 (0.55) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL6183753 0.87 CCNB2 (0.55) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL9857485 0.85 CCNB2 (0.64) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL12379205 0.85 CCNB2 (0.64) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL7293378 0.85 CCNB2 (0.64) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL9871990 0.85 CCNB2 (0.64) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL9857489 0.85 CCNB2 (0.64) CCNB2CDK1CDK4CCNB1CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed